Fresh Meadows, New York Clinical Trials

A listing of Fresh Meadows, New York clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 414 clinical trials
A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy

The researchers are doing this study to find out whether the study drug hydroxychloroquine can prevent infection with the COVID-19 virus, compared with placebo, in people who are receiving radiation therapy for their cancer. The placebo used in this study is a tablet that looks the same as the study …

chills
anosmia
pharyngitis
sore throat
nervous
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
 (8.9 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +6 other locations
ctgov trial 2

    dddd

Test Site
 (9.7 away) Contact site
  • 0 views
  • 20 Aug, 2020
  • 1 location
Safety Pharmacokinetics and Preliminary Efficacy of Isatuximab in Patients Awaiting Kidney Transplantation

Primary Objectives: Phase 1: To characterize the safety and tolerability of isatuximab in kidney transplant candidates. Phase 2: To evaluate the efficacy of isatuximab in desensitization of patients awaiting kidney transplantation. Secondary Objectives: Phase 2: To characterize the safety profile of isatuximab in kidney transplant candidates. To characterize the pharmacokinetic …

chronic kidney disease
kidney transplant
sar650984
diphenhydramine
nephropathy
Investigational Site Number 8400002
 (9.7 away) Contact site
  • 0 views
  • 12 Nov, 2020
  • +2 other locations
First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple Myeloma

Primary Objectives: Dose Escalation Part A: To determine the maximum tolerated dose (MTD) of SAR442085 administered as a single agent in patients with relapsed or refractory multiple myeloma (RRMM), and determine the recommended Phase 2 dose (RP2D) for the subsequent Expansion Part B Dose Expansion Part B: To assess the …

therapy
immunotherapeutic agent
carfilzomib
proteasome inhibitor
ixazomib
Investigational Site Number 8400001
 (8.7 away) Contact site
  • 0 views
  • 04 Dec, 2020
  • +7 other locations
Distal Peripheral Neuropathy in Type 2 Diabetes (DSP/DM)  

Distal sensory peripheral neuropathy (DSP) is a chronic, debilitating painful condition affecting quality of life in persons living with Type 2 diabetes. Treatments prescribed to manage DSP pain, such as nonnarcotic and narcotic analgesics, antidepressants and anticonvulsants, are largely ineffective. This is a preliminary study at assessing the feasibility, efficiency …

New York University, Division of Special Studies in Symptom Management
 (9.7 away)
  • 0 views
  • 26 Sep, 2022
  • +2 other locations
Berberine Supplementation, Sprint Interval Training, and Immune Function Study  

The purpose of this clinical trial is to investigate the effects of a 2-week intervention involving berberine supplementation or sprint training in isolation as well as berberine combined with sprint training on well-being, anaerobic power, and monocyte number and function in individuals experiencing mild mental health challenges. The main questions …

Accepts healthy volunteers
New York Medical and Diagnostic Center
 (2.5 away)
  • 0 views
  • 03 Jul, 2026
  • +2 other locations
PPMI 2.0 Clinical -Establishing a Deeply Phenotyped PD Cohort

The Parkinson Progression Marker Initiative 2.0 (PPMI 2.0) is a longitudinal, observational, multi-center natural history study to assess progression of clinical features, digital outcomes, and imaging, biologic and genetic markers of Parkinson's disease (PD) progression in study participants with manifest PD, prodromal PD, and healthy controls The overall goal of …

alpha-synuclein
methyldopa
genetic testing
resting tremor
datscan
NYU Langone Health
 (9.2 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +45 other locations
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry

The ICGG Gaucher Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Gaucher disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician. The …

deficiency
imiglucerase
gaucher disease
eliglustat
Investigational Site Number 840102
 (7.1 away) Contact site
  • 0 views
  • 04 Dec, 2020
  • +208 other locations
Mucopolysaccharidosis I (MPS I) Registry

The Mucopolysaccharidosis I (MPS I) Registry is an ongoing, observational database that tracks the outcomes of patients with MPS I. The data collected by the MPS I Registry will provide information to better characterize the natural history and progression of MPS I as well as the clinical responses of patients …

Investigational Site Number 840102
 (7.1 away) Contact site
  • 0 views
  • 04 Dec, 2020
  • +124 other locations
Pompe Disease Registry

The Pompe Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Pompe disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician. The objectives …

replacement therapy
glycogen storage disease type ii
deficiency
gaa gene
myozyme
Investigational Site Number 840102
 (7.1 away) Contact site
  • 0 views
  • 22 Dec, 2020
  • +168 other locations